Interdisciplinary imaging studies – such as computed tomography (CT), magnetic
resonance imaging (MRI), and positron emission tomography (PET) scans – have
become standard in oncology diagnostic evaluations. The type and frequency of
examinations depend on the origin of the tumor and clinical scenario.
Read more about syngo.via, Siemens' new imaging software.
more
* syngo.via can be used as a stand-alone device or together with a variety of syngo.via-based software options which are medical devices on their own rights. These products are pending regulatory clearance in some countries and therefore not yet commercially available in all countries. In particular the products are not yet available for sales in Brazil. syngo.via can be used anywhere if the following prerequisites are given: Internet connection to clinical network, DICOM compliance, meeting of Siemens minimum hardware requirements, and adherence to local data security regulations. Usage of syngo.via in operating room or for an emergency case requires customer to provide respective emergency measures in case of non-availability of system or network.
** Prerequisites include: Internet connection to clinical network, DICOM compliance, meeting of minimum hardware requirements, and adherence to local data security regulations.
Once a lesion has been detected, precise staging is key
to fighting cancer effectively. You need to investigate the
tumor for size and other signs of malignancy and determine
whether and where the tumor has metastasized.
syngo.via comes with a variety of tools and features to
support you during lesion detection and evaluation.
Automated case preparation
With syngo.via, reading physicians can immediately focus on the essentials: images
and diagnosing. When opening a patient’s file, images are already complete, prepared,
and ready to be read. syngo.via loads oncology cases to the appropriate application,
pre-processes the images according to disease-specific requirements, sorts them into
a synchronized dedicated layout, and gathers previous image data from archives.
For example, for each MR whole body study, syngo.via automatically structures and
sorts all images from head to toe, from soft tissue to bone contrast. Follow-up studies
and all prior studies are loaded and displayed in a “compare layout.”
In short, you leave the preparation to syngo.via in order to reduce time spent preparing
data and concentrate more on reading and increasing throughput.
Structured case navigation
syngo.via helps make oncology reading fast, intuitive, and less error prone. It enhances
handling of large amounts of data and provides a high degree of automation and
advanced ergonomics to help physicians focus on the essentials.
The automatic anatomic registration facilitates synchronized scrolling, zooming and
rotating, and new tools like 3D Reference Point allow fast localization of the same
point in all series and planes. With syngo.via, the reading physician can just follow the
suggested pre-defined workflow steps throughout the complete dataset and read the
case faster and easier, even when comparing follow-up exams with previous ones.
What’s more, suggested workflows are specific to the type of modality and to the case
at hand and you can customize the complete workflow to suit your needs.
See the whole picture: Drag and drop to combine additional image datasyngo.via is a true multi-modality platform that provides all tools necessary to read and to share images from PET, CT, MR, CR/DR digital X-ray, fluoroscopy, angiography, and ultrasound. syngo.via also allows combinations of images from multiple modalities whenever needed – to give you additional and potentially decisive information for your oncology cases. Should any additional image data from other modalities or previous scans be available for your patient, you can easily drag and drop them into your oncology reading layout. These images will be registered automatically with the data sets already in use and displayed on up to two monitors. For example, you could easily create side-by-side displays of MR and ultrasound images for prostate cases, or use automatic image fusion for CT, MR, and PET images to read brain and other cases. In sum, this gives you the edge in diagnostic information for oncology reading.
Images – the way you want themsyngo.via offers the 2D and 3D capabilities you want. Flexible screen layouts and dual-monitor support allow you to switch instantly between 2D- and 3D-reading strategies so you can combine with ease the advantages of both. For example, switch to 3D views of any contrast with just one click in MR Reading – without changing the software or task card – or switch instantly between the 3D endoscopic view and the corresponding 2D images within syngo.CT Colonography.
Seamless integration of second reader tools and shared reading to enhance diagnostic confidence
Using syngo.via’s computer-aided detection (CAD) tools as a second reader can help
improve diagnostic confidence while maintaining a fast and efficient workflow. The second
reader tools include syngo.CXR CAD** for the detection of lung nodules in digital chest
X-ray studies; syngo.CT Lung CAD for the detection of solid pulmonary nodules in
diagnostic chest CT exams; and syngo.CT Colonography – PEV (Polyp Enhanced Viewing)***
for use in CT colonography exams.
In addition to these second reader tools, syngo.via facilitates live collaboration between
two syngo.via clients through desktop sharing. This allows you to easily ask a colleague
for a second opinion, without needing to leave the case.
Lesion segmentation – you mark the lesion, syngo.via the boundariessyngo.via provides dedicated automated and accurate segmentation and quantification functionalities. All you need to do is to select the lesion and syngo.via generates a boundary around the lesion and computes its volume – there is no need to spend time on manual 3D segmentations. syngo.via with the syngo.mCT Oncology* Engine Pro provides a unique integration of PET and CT segmentation tools: SUV-based 3D iso-contouring is available in the same application with automated CT lung, liver, and lymph segmentation tools. This facilitates accurate staging and total tumor burden assessment.
Measurements for daily work and for research – automated and reproducibleWith syngo.via, you can measure a distance, a region of interest (ROI), or mark a suspicious lesion with a single click. For further evaluation of the lesion within the images, syngo.via offers a variety of automated and thus reproducible measurements adequate for daily work and for research purposes, such as RECIST 1.0 and WHO diameters, mean HU, multiple SUV calculation methods, doubling time, shape parameters, and histogram. Besides calcualtion of diameters, syngo.via with the syngo.mCT Oncology* Engine, with the syngo.CT Oncology Engine, or with the syngo.MR Onco Engine are also capable of automated volume measurement of a lesion by calculating the space enclosed within the segmented tumor, leading to high reproducibility of measurements and thus helping to reduce inter-reader or intra-reader variability.
* Regulatory clearance with syngo.PET&CT Oncology.
** Not available for sale in the U.S.
*** Not classified as a CAD product in the U.S.
syngo.via can be used as a stand-alone device or together with a variety of syngo.via-based software options which are medical devices on their own rights. These products are pending regulatory clearance in some countries and therefore not yet commercially available in all countries. In particular the products are not yet available for sales in Brazil.
syngo.via can be used anywhere if the following prerequisites are given: Internet connection to clinical network, DICOM compliance, meeting of Siemens minimum hardware requirements, and adherence to local data security regulations.
Usage of syngo.via in operating room or for an emergency case requires customer to provide respective emergency measures in case of non-availability of system or network.
Combined with additional diagnostic parameters, imaging guides the cancer therapy. Diagnostic and staging information from imaging helps you to select the appropriate treatment modality and plan the treatment, be it surgery, interventional oncology procedures, radiation therapy, chemotherapy, or a combination. This also aids therapy prognosis and can be used to monitor treatment response.
Interventional oncology procedures – a variety of minimally invasive, image-guided
tumor therapies such as transcatheter therapies and ablative therapies – are dependent
on highly sophisticated imaging applications during all phases of the tumor treatment
workflow. Together with its applications, syngo.via supports enhanced procedural planning for effective preparation
of an intervention, and thereby supports high-quality clinical outcomes with the least
possible physiological stress or toxic load for the patient. Anatomical and
functional image information from multiple modalities can be loaded, assessed in sideby-
side-view, or fused in order to support treatment decisions. syngo.via-based applications dedicated to quantitative 3D evaluation of organs and tumors – such as tumor volume
measurement or evaluation of blood flow or blood volume – help determine the optimal
amount of drugs, embolization particles, or radioactive spheres to be applied during
intervention. In addition, they support access path planning and assessment of
tumor feeding vessels.
The syngo.via client-server architecture helps to ensure that pre-interventional 2D and
3D images as well as measurements and treatment planning data will be at hand in
the lab where the intervention ultimately takes place. It also brings diagnostic imaging
information from other diagnostic modalities directly into the interventional suite*.
Finally, using the collaboration mode of syngo.via, interventional images can be instantly
shared with other clinicians, thus allowing the consultation of experts during intervention.
* Usage of syngo.via in the interventional suite or for an emergency case requires customer to provide
respective emergency measures in case of non-availability of system or network.
syngo.via can be used as a stand-alone device or together with a variety of syngo.via-based software options which are medical devices on their own rights. These products are pending regulatory clearance in some countries and therefore not yet commercially available in all countries. In particular the products are not yet available for sales in Brazil.
syngo.via can be used anywhere if the following prerequisites are given: Internet connection to clinical network, DICOM compliance, meeting of Siemens minimum hardware requirements, and adherence to local data security regulations.
Usage of syngo.via in operating room or for an emergency case requires customer to provide respective emergency measures in case of non-availability of system or network.
Imaging is of key importance to truly assess the effect of a
treatment, as early as possible. Intra-therapy imaging can
be an effective tool to assess therapy response, even before
a treatment phase is complete. The prognostic power of PET
imaging helps in effective and efficient patient management,
as changes in metabolic activity can be detected even before
changes in size are visible.
syngo.via provides powerful functionalities to assist you in the
evaluation of the change of tumor status in cancer patients.
Time-point comparisonsOncology follow-up is all about comparing cancer at different points in time. syngo.via’s Automatic Case Preparation virtually reads your mind: It automatically gathers images from your archives and arranges them in the layout and order you prefer to read them. Tumor follow-ups no longer require you to search for patients and images in data bases. Current and prior studies are displayed for you immediately in your preferred layout on up to two monitors, for a comprehensive and intuitive follow-up assessment.
Therapy response assessment: Know if the tumor is growing, stable, or shrinkingAccuracy and reproducibility are key factors in tumor assessment. Findings from prior exams are automatically propagated to follow-up, and results regarding tumor growth are instantly provided within the context-specific report. Auto measurements of RECIST 1.0, WHO, and tumor volume through syngo.via in CT images, as well as SUV quantification on PET allow more objective measurements and a better reproducibility of results because inter-reader or intra-reader dependencies are eliminated. In addition, the tumor growth rates and tumor burden can be calculated automatically. In case additional image data from MRI or PET is available for your patient, you can easily drag and drop them into your oncology reading layout. These images will be registered automatically with the CT data sets and displayed on up to two monitors. The anatomic registration facilitates synchronized scrolling and 3D case navigation, regardless of the slice thickness. Last but not least,syngo.via with the syngo.mCT Oncology* Engine Pro enables you to segment and quantify lesions in 3D on both PET and CT. Trending these parameters over time provides valuable information for therapy response assessment.
* Regulatory clearance with syngo.PET&CT Oncology.
syngo.via can be used as a stand-alone device or together with a variety of syngo.via-based software options which are medical devices on their own rights. These products are pending regulatory clearance in some countries and therefore not yet commercially available in all countries. In particular the products are not yet available for sales in Brazil.
syngo.via can be used anywhere if the following prerequisites are given: Internet connection to clinical network, DICOM compliance, meeting of Siemens minimum hardware requirements, and adherence to local data security regulations.
Usage of syngo.via in operating room or for an emergency case requires customer to provide respective emergency measures in case of non-availability of system or network.
Finding, not searching: Findings Navigator
Keeping track of findings in oncology imaging over the entire patient history can sometimes be quite a challenge. Multiple lesions, multiple time-points, and multiple readers can often result in countless findings. syngo.via’s unique Findings Navigator automatically collects all your findings on-the-fly while you read the case. You never need to repeat what you have already finished. With the Findings Navigator, retrieving and toggling between findings for detailed information about a lesion’s properties is as easy as a single click. It will always bring you back to the same context as when you first collected the finding: the same 2D or 3D image, the same layout, and the same window settings – a bit of a “findings déjà vu.” The Findings Navigator facilitates accelerated reading and your list of findings can be elegantly used as bookmarks during clinical demonstrations such as tumor board meetings.
Insightful disease orientationWith syngo.via, you can create disease-specific reports* right away. These are tailored reports that allow the reading physician to make statements about the overall impression and therapy recommendations. For example, in tumor evaluation, context-specific tools such as fast 3D lesion segmentation can provide results in seconds. The dedicated oncology report visualizes the diagnosis and provides important facts and results from imaging and biopsies at one glance – including key images and findings details, such as quantitative results per lesion and change over time for trending analysis.
Effective information sharing with clinicians and effective communication with patients
The reading physician needs to effectively share results with clinical partners involved in each case – and results need to be communicated to patients. This can be easily done with syngo.via and its networked setup; creating new possibilities like easy second opinion and on-call scenarios: Reading physicians can use the Findings Navigator to elegantly present cases or distribute the context-specific reports to referring physicians. Clinical partners in different locations can review CT, MR, and PET data the way they need. For example, surgeons can plan an intervention by navigating through the case in 3D, instead of looking at static 2D images. Oncologists can review lesions with advanced measurement tools. Referring physicians can access syngo.via WebReport** to review findings and related images. Last but not least, 3D visualization can be used for patient communication.
No imaging field changes as quickly as oncology imaging - from morphology to function, from CT to multimodality imaging including PET/CT and MRI. Watch a recording of a webcast, held by Anno Graser, MD (University of Munich, Germany). He focuses on future trends, reviews the current status of oncology imaging, and shows oncology cases on Siemens' cutting edge syngo.via solution.
* The disease-specific report created in syngo.via is not the final diagnostic report.
The final diagnostic report is generated and signed off within the RIS. Archiving of diagnostic reports is the responsibility of the RIS.
**The information about this product is preliminary, it is under development and does not have the necessary clearances in any country. Its future availability cannot be ensured. It is not available for sale in the U.S., China or Brazil. The application is not for Diagnostic Use.
syngo.via can be used as a stand-alone device or together with a variety of syngo.via-based software options which are medical devices on their own rights. These products are pending regulatory clearance in some countries and therefore not yet commercially available in all countries. In particular the products are not yet available for sales in Brazil.
syngo.via can be used anywhere if the following prerequisites are given: Internet connection to clinical network, DICOM compliance, meeting of Siemens minimum hardware requirements, and adherence to local data security regulations.
Usage of syngo.via in operating room or for an emergency case requires customer to provide respective emergency measures in case of non-availability of system or network.